Amedeo Smart

Free Medical Literature Service




  Free Subscription

Articles published in
Kidney Int
    July 2017
  1. OWENS EA, Jie L, Reyes BAS, Van Bockstaele EJ, et al
    Elastin insufficiency causes hypertension, structural defects and abnormal remodeling of renal vascular signaling.
    Kidney Int. 2017 Jul 26. pii: S0085-2538(17)30352.
    >> Share

    June 2017
  2. TITZE J, Luft FC
    Speculations on salt and the genesis of arterial hypertension.
    Kidney Int. 2017;91:1324-1335.
    >> Share

  3. VAN LAECKE S, Van Biesen W
    Severe hypertension with renal thrombotic microangiopathy: what happened to the usual suspect?
    Kidney Int. 2017;91:1271-1274.
    >> Share

    April 2017
  4. HOY WE, Kopp JB, Mott SA, Winkler CA, et al
    Absence of APOL1 risk alleles in a remote living Australian Aboriginal group with high rates of CKD, hypertension, diabetes, and cardiovascular disease.
    Kidney Int. 2017;91:990.
    >> Share

    February 2017
  5. TIMMERMANS SA, Abdul-Hamid MA, Vanderlocht J, Damoiseaux JG, et al
    Patients with hypertension-associated thrombotic microangiopathy may present with complement abnormalities.
    Kidney Int. 2017 Feb 7. pii: S0085-2538(16)30742.
    >> Share

    January 2017
  6. KOBAYASHI R, Wakui H, Azushima K, Uneda K, et al
    An angiotensin II type 1 receptor binding molecule has a critical role in hypertension in a chronic kidney disease model.
    Kidney Int. 2017 Jan 4. pii: S0085-2538(16)30650.
    >> Share

    October 2016
  7. VAN DEN BORN BJ, Oskam LC, Zidane M, Schachterle C, et al
    The Case| A handful of hypertension.
    Kidney Int. 2016;90:911-3.
    >> Share

    September 2016
  8. HALLER ST, Kumarasamy S, Folt DA, Wuescher LM, et al
    Targeted disruption of Cd40 in a genetically hypertensive rat model attenuates renal fibrosis and proteinuria, independent of blood pressure.
    Kidney Int. 2016 Sep 28. pii: S0085-2538(16)30443.
    >> Share

  9. WYATT CM, Chertow GM
    Clinical trials of intensive versus less intensive control of hypertension: HOPE or HYPE?
    Kidney Int. 2016;90:460-2.
    >> Share

    August 2016
  10. KURTZ TW, DiCarlo SE, Pravenec M, Schmidlin O, et al
    An alternative hypothesis to the widely held view that renal excretion of sodium accounts for resistance to salt-induced hypertension.
    Kidney Int. 2016 Aug 18. pii: S0085-2538(16)30310.
    >> Share

    Hypertension and glomerular function decline: the chicken or the egg?
    Kidney Int. 2016;90:254-6.
    >> Share

    May 2016
  12. BETZ BB, Jenks SJ, Cronshaw AD, Lamont DJ, et al
    Urinary peptidomics in a rodent model of diabetic nephropathy highlights epidermal growth factor as a biomarker for renal deterioration in patients with type 2 diabetes.
    Kidney Int. 2016;89:1125-35.
    >> Share

    April 2016
  13. BENGHANEM GHARBI M, Elseviers M, Zamd M, Belghiti Alaoui A, et al
    Chronic kidney disease, hypertension, diabetes, and obesity in the adult population of Morocco: how to avoid "over"- and "under"-diagnosis of CKD.
    Kidney Int. 2016 Apr 13. pii: S0085-2538(16)00369.
    >> Share

    Promising biomarkers for superimposed pre-eclampsia in pregnant women with established hypertension and chronic kidney disease.
    Kidney Int. 2016;89:743-6.
    >> Share

    February 2016
  15. TAVASOLI M, Li L, Al-Momany A, Zhu LF, et al
    The chloride intracellular channel 5A stimulates podocyte Rac1, protecting against hypertension-induced glomerular injury.
    Kidney Int. 2016 Feb 24. pii: S0085-2538(16)00220.
    >> Share

  16. ZAIDAN M, Koumakis E, Karras A, Bruneval P, et al
    The Case | A man with hypertension, respiratory distress, and rapidly progressive renal failure.
    Kidney Int. 2016;89:509-10.
    >> Share

  17. ROCCO MV, Cheung AK
    A SPRINT to the finish, or just the beginning? Implications of the SPRINT results for nephrologists.
    Kidney Int. 2016;89:261-3.
    >> Share

    January 2016
  18. BRAMHAM K, Seed PT, Lightstone L, Nelson-Piercy C, et al
    Diagnostic and predictive biomarkers for pre-eclampsia in patients with established hypertension and chronic kidney disease.
    Kidney Int. 2016 Jan 19. pii: S0085-2538(15)00127.
    >> Share

  19. FLOEGE J, Rauen T
    Immunosuppression in IgA nephropathy: how certain are we?
    Kidney Int. 2016;89:9-11.
    >> Share

    June 2015
  20. LIAO JN, Chao TF, Liu CJ, Wang KL, et al
    Incidence and risk factors for new-onset atrial fibrillation among patients with end-stage renal disease undergoing renal replacement therapy.
    Kidney Int. 2015;87:1209-15.
    >> Share

    May 2015
  21. REDDY MA, Natarajan R
    Recent developments in epigenetics of acute and chronic kidney diseases.
    Kidney Int. 2015 May 20. doi: 10.1038/ki.2015.
    >> Share

  22. KU E, Glidden DV, Johansen KL, Sarnak M, et al
    Association between strict blood pressure control during chronic kidney disease and lower mortality after onset of end-stage renal disease.
    Kidney Int. 2015;87:1055-60.
    >> Share

    April 2015
  23. RUMP LC, Stegbauer J
    Coronary artery stenosis: a new risk factor for chronic kidney injury?
    Kidney Int. 2015;87:676-7.
    >> Share

  24. PALLET N, Mami I, Schmitt C, Karim Z, et al
    High prevalence of and potential mechanisms for chronic kidney disease in patients with acute intermittent porphyria.
    Kidney Int. 2015 Apr 1. doi: 10.1038/ki.2015.
    >> Share

    February 2015
  25. DRECHSLER C, Kalim S, Wenger JB, Suntharalingam P, et al
    Protein carbamylation is associated with heart failure and mortality in diabetic patients with end-stage renal disease.
    Kidney Int. 2015 Feb 11. doi: 10.1038/ki.2014.
    >> Share

    January 2015
  26. MOLITCH ME, Adler AI, Flyvbjerg A, Nelson RG, et al
    Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes.
    Kidney Int. 2015;87:20-30.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016